Cartesian Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.About RNAC
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates.
RNAC Key Statistics
Stock Snapshot
As of today, Cartesian Therapeutics(RNAC) shares are valued at $7.80. The company's market cap stands at 228.59M, with a P/E ratio of -1.35.
Cartesian Therapeutics(RNAC) stock opened on 2026-08-03 at $7.77. The price climbed to — and dipped to —.
Cartesian Therapeutics(RNAC) shares are trading with a volume of 0, against a daily average of 122.96K.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $13.10 and a 52-week low of $5.60.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $13.10 and a 52-week low of $5.60.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.